Advanced search
Publication Cover
Acta Oncologica Volume 54, 2015 - Issue 9
Journal homepage
2,013
Views
16
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Imaging of tumour hypoxia and metabolism in patients with head and neck squamous cell carcinoma

Catharina M. L. ZegersDepartment of Radiation Oncology (MAASTRO), GROW – School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The NetherlandsCorrespondence[email protected]
,
Wouter van ElmptDepartment of Radiation Oncology (MAASTRO), GROW – School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands
,
Frank J. P. HoebersDepartment of Radiation Oncology (MAASTRO), GROW – School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands
,
Esther G. C. TroostDepartment of Radiation Oncology (MAASTRO), GROW – School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands;Helmholtz Zentrum Dresden-Rossendorf, Dresden, Germany;OncoRay, Department of Radiation Oncology, Medical Faculty and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany
,
Michel C. ÖllersDepartment of Radiation Oncology (MAASTRO), GROW – School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands
,
Felix M. MottaghyDepartment of Nuclear Medicine, Maastricht University Medical Centre, Maastricht, The Netherlands;Department of Nuclear Medicine, RWTH Aachen University, University Hospital, Aachen, Germany
&
Philippe LambinDepartment of Radiation Oncology (MAASTRO), GROW – School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands
 show all
Pages 1378-1384 | Received 14 May 2015, Accepted 19 Jun 2015, Published online: 27 Jul 2015

Citations (16)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Morten Busk, Michael R. Horsman, Jens Overgaard & Steen Jakobsen. (2019) Dual-tracer PET of viable tumor volume and hypoxia for identification of necrosis-containing radio-resistant Sub-volumes. Acta Oncologica 58:10, pages 1476-1482.
Read now
Cai Grau, Morten Høyer, Per Rugaard Poulsen, Ludvig Paul Muren, Stine Sofia Korreman, Kari Tanderup, Jacob Christian Lindegaard, Jan Alsner & Jens Overgaard. (2017) Rethink radiotherapy – BIGART 2017. Acta Oncologica 56:11, pages 1341-1352.
Read now
Aniek J. G. Even, Bart Reymen, Matthew D. La Fontaine, Marco Das, Arthur Jochems, Felix M. Mottaghy, José S. A. Belderbos, Dirk De Ruysscher, Philippe Lambin & Wouter van Elmpt. (2017) Predicting tumor hypoxia in non-small cell lung cancer by combining CT, FDG PET and dynamic contrast-enhanced CT. Acta Oncologica 56:11, pages 1591-1596.
Read now
Emely Lindblom, Alexandru Dasu, Johan Uhrdin, Aniek Even, Wouter van Elmpt, Philippe Lambin, Peter Wersäll & Iuliana Toma-Dasu. (2017) Defining the hypoxic target volume based on positron emission tomography for image guided radiotherapy – the influence of the choice of the reference region and conversion function. Acta Oncologica 56:6, pages 819-825.
Read now
Cai Grau, Jens Overgaard, Morten Høyer, Kari Tanderup, Jacob Christian Lindegaard & Ludvig Paul Muren. (2015) Biology-guided adaptive radiotherapy (BiGART) is progressing towards clinical reality. Acta Oncologica 54:9, pages 1245-1250.
Read now

Articles from other publishers (11)

Claudia F. E. Kirsch. 2022. Hybrid PET/MR Neuroimaging. Hybrid PET/MR Neuroimaging 639 655 .
Charles Marcus & Rathan M. Subramaniam. (2021) Role of Non-FDG-PET/CT in Head and Neck Cancer. Seminars in Nuclear Medicine 51:1, pages 68-78.
Crossref
Hong Yuan, Gregory M. Palmer & Mark W. Dewhirst. 2021. Molecular Imaging. Molecular Imaging 869 895 .
Sebastian Sanduleanu, Arthur Jochems, Taman Upadhaya, Aniek J.G. Even, Ralph T.H. Leijenaar, Frank J.W.M. Dankers, Remy Klaassen, Henry C. Woodruff, Mathieu Hatt, Hans J.A.M. Kaanders, Olga Hamming-Vrieze, Hanneke W.M. van Laarhoven, Rathan M. Subramiam, Shao Hui Huang, Brian O'Sullivan, Scott V. Bratman, Ludwig J. Dubois, Razvan L. Miclea, Dario Di Perri, Xavier Geets, Mireia Crispin-Ortuzar, Aditya Apte, Joseph O. Deasy, Jung Hun Oh, Nancy Y. Lee, John L. Humm, Heiko Schöder, Dirk De Ruysscher, Frank Hoebers & Philippe Lambin. (2020) Non-invasive imaging prediction of tumor hypoxia: A novel developed and externally validated CT and FDG-PET-based radiomic signatures. Radiotherapy and Oncology 153, pages 97-105.
Crossref
Paulina Cegla, Kazmierska Joanna, Gwozdz Sebastian, Malicki Julian, Smolen Michal & Cholewinski Witold. (2019) Correlation between tumour biology status measured in triple-tracer 18F-fluorodeoxyglucose–18F-fluorothymidine– 18F-fluoromisonidazole-PET/CT study and human papillomavirus status in patients with head and neck cancer. Nuclear Medicine Communications 40:7, pages 752-757.
Crossref
Helen M. Betts, Richard A. O’Connor, Judith A. Christian, Vidhiya Vinayakamoorthy, Karen Foweraker, Abigail C. Pascoe & Alan C. Perkins. (2019) Hypoxia imaging with [18F]HX4 PET in squamous cell head and neck cancers. Nuclear Medicine Communications 40:1, pages 73-78.
Crossref
Olga Hamming-Vrieze, Arash Navran, Abrahim Al-Mamgani & Wouter V. Vogel. (2018) Biological PET-guided adaptive radiotherapy for dose escalation in head and neck cancer: a systematic review. The Quarterly Journal of Nuclear Medicine and Molecular Imaging 62:4.
Crossref
F.M. Mottaghy. (2017) Non-invasive molecular imaging and theranostic probes. Methods 130, pages 1-3.
Crossref
Jurgen Peerlings, Lien Van De Voorde, Cristina Mitea, Ruben Larue, Ala Yaromina, Sebastian Sandeleanu, Linda Spiegelberg, Ludwig Dubois, Philippe Lambin & Felix M. Mottaghy. (2017) Hypoxia and hypoxia response-associated molecular markers in esophageal cancer: A systematic review. Methods 130, pages 51-62.
Crossref
Sjoukje F. Oosting, Elisabeth G. E. de Vries & Max J. H. Witjes. 2017. Critical Issues in Head and Neck Oncology. Critical Issues in Head and Neck Oncology 77 96 .
Ruben T. H. M. Larue, Lien Van De Voorde, Maaike Berbée, Wouter J. C. van Elmpt, Ludwig J. Dubois, Kranthi M. Panth, Sarah G. J. A. Peeters, Ann Claessens, Wendy M. J. Schreurs, Marius Nap, Fabiënne A. R. M. Warmerdam, Frans L. G. Erdkamp, Meindert N. Sosef & Philippe Lambin. (2016) A phase 1 ‘window-of-opportunity’ trial testing evofosfamide (TH-302), a tumour-selective hypoxia-activated cytotoxic prodrug, with preoperative chemoradiotherapy in oesophageal adenocarcinoma patients. BMC Cancer 16:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.